Status:
COMPLETED
Neurology Measures in FA Children
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
University of Florida
University of California, Los Angeles
Conditions:
Friedreich Ataxia
Eligibility:
All Genders
2-18 years
Brief Summary
The purpose of this study is to identify ways to follow progression of Friedreich's Ataxia (FA) and be able to measure changes over time in children with FA. Participants will have biannual visits to ...
Detailed Description
Investigators seek to identify biological and clinical tests to be used in future clinical trials. The purpose of this research study is to learn more about Friedreich's Ataxia (FA) progression in chi...
Eligibility Criteria
Inclusion
- Males or females age 2 to 18 years.
- Genetically confirmed diagnosis of Friedreich's Ataxia (FA) or clinically confirmed diagnosis of FA, pending confirmatory genetic testing through a commercial or research laboratory
- Parental/guardian permission (informed consent) and if appropriate, child assent.
Exclusion
- 1\) Inability to complete study evaluations
Key Trial Info
Start Date :
November 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 2 2023
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03418740
Start Date
November 20 2017
End Date
February 2 2023
Last Update
January 16 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
2
University of Florida
Gainesville, Florida, United States, 32611
3
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104